Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer

NCT00548418 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Topotecan
DRUG: Cisplatin
DRUG: Bevacizumab

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]